These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8930408

  • 21. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.
    Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ.
    J Cell Physiol; 1994 Jul; 160(1):194-202. PubMed ID: 7517405
    [Abstract] [Full Text] [Related]

  • 22. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
    Wang M, Fudge K, Rhim JS, Stearns ME.
    Oncol Res; 1996 May 01; 8(7-8):303-15. PubMed ID: 8938794
    [Abstract] [Full Text] [Related]

  • 25. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS.
    Lab Invest; 2004 Jan 01; 84(1):8-20. PubMed ID: 14631378
    [Abstract] [Full Text] [Related]

  • 26. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
    Rao CN, Reddy P, Reeder DJ, Liu Y, Stack SM, Kisiel W, Woodley DT.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1286-94. PubMed ID: 11027624
    [Abstract] [Full Text] [Related]

  • 27. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
    Miyake H, Hara I, Gohji K, Yamanaka K, Hara S, Arakawa S, Nakajima M, Kamidono S.
    Clin Cancer Res; 1999 Oct 05; 5(10):2824-9. PubMed ID: 10537348
    [Abstract] [Full Text] [Related]

  • 28. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.
    Baker AH, Zaltsman AB, George SJ, Newby AC.
    J Clin Invest; 1998 Mar 15; 101(6):1478-87. PubMed ID: 9502791
    [Abstract] [Full Text] [Related]

  • 29. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.
    Padgett LC, Lui GM, Werb Z, LaVail MM.
    Exp Eye Res; 1997 Jun 15; 64(6):927-38. PubMed ID: 9301473
    [Abstract] [Full Text] [Related]

  • 30. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.
    Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D.
    Am J Pathol; 1997 May 15; 150(5):1647-59. PubMed ID: 9137090
    [Abstract] [Full Text] [Related]

  • 31. Metastatic NIH 3T3 x LTA cell hybrids express 72 kDa type IV collagenase.
    Xuan JW, Wilson SM, Chin JL, Chambers AF.
    Anticancer Res; 1995 May 15; 15(4):1227-33. PubMed ID: 7654002
    [Abstract] [Full Text] [Related]

  • 32. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
    Emenaker NJ, Basson MD.
    J Surg Res; 1998 Apr 15; 76(1):41-6. PubMed ID: 9695737
    [Abstract] [Full Text] [Related]

  • 33. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ, Vincent KJ, Arthur MJ, Fowler AV, Smart DE, Wright MC, Clark IM, Benyon RC, Iredale JP, Mann DA.
    Hepatology; 1999 Mar 15; 29(3):839-48. PubMed ID: 10051488
    [Abstract] [Full Text] [Related]

  • 34. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D.
    Am J Pathol; 1997 Feb 15; 150(2):653-66. PubMed ID: 9033278
    [Abstract] [Full Text] [Related]

  • 35. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
    Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP.
    Eur J Cell Biol; 1997 Oct 15; 74(2):111-22. PubMed ID: 9352216
    [Abstract] [Full Text] [Related]

  • 36. Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA.
    Takaoka K, Kishimoto H, Segawa E, Hashitani S, Zushi Y, Noguchi K, Sakurai K, Urade M.
    Int J Oncol; 2006 Nov 15; 29(5):1095-101. PubMed ID: 17016639
    [Abstract] [Full Text] [Related]

  • 37. ACTH induces TIMP-1 expression and inhibits collagenase in adrenal cortex cells.
    Reichenstein M, Reich R, LeHoux JG, Hanukoglu I.
    Mol Cell Endocrinol; 2004 Feb 27; 215(1-2):109-14. PubMed ID: 15026182
    [Abstract] [Full Text] [Related]

  • 38. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
    Sakaida I, Hironaka K, Kimura T, Terai S, Yamasaki T, Okita K.
    Life Sci; 2004 Mar 19; 74(18):2251-63. PubMed ID: 14987950
    [Abstract] [Full Text] [Related]

  • 39. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR, Kim CH.
    Int J Biochem Cell Biol; 2004 Nov 19; 36(11):2293-306. PubMed ID: 15313474
    [Abstract] [Full Text] [Related]

  • 40. Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs.
    Kossakowska AE, Urbanski SJ, Huchcroft SA, Edwards DR.
    Oncol Res; 1992 Nov 19; 4(6):233-40. PubMed ID: 1421616
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.